Bank of America Corporation »

Verve Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.3M 238k 13.94
2023-09-30 $4.2M 315k 13.26
2023-06-30 $3.2M 173k 18.75
2023-03-31 $5.5M 385k 14.42
2022-12-31 $10M 535k 19.35
2022-06-30 $287k 19k 15.29
2021-12-31 $1.9M 51k 36.87
2021-06-30 $22k 372 59.14